Controlled Study of aNew Five-Component Acellular Pertussis Vaccine in Adults and Young Children
JA Englund, WP Glezen, L Barreto - Journal of Infectious …, 1992 - academic.oup.com
A new five-component acellular pertussis (AP) vaccine containing 10 µLg of pertussis toxoid,
S µg of filamentous hemagglutinin, 5 jµ of combined agglutinogens 2 and 3, and 3 µg of …
S µg of filamentous hemagglutinin, 5 jµ of combined agglutinogens 2 and 3, and 3 µg of …
Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in …
AE Tozzi, A Anemona, D Stat, P Stefanelli… - …, 2001 - publications.aap.org
Objectives. To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …
Antibody response and reactions to completion of a four-dose series with a two-or three-component acellular pertussis vaccine compared to whole cell pertussis …
ME Pichichero, JL Green, AB Francis… - … journal of infectious …, 1996 - Taylor & Francis
We compared the reactions and immunogenicity of DT acellular pertussis (DTaP) vaccines
containing pertussis toxoid (PT) and filamentous haemagglutinin (FHA)(2-component DTaP) …
containing pertussis toxoid (PT) and filamentous haemagglutinin (FHA)(2-component DTaP) …
Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15–24 months and 4–6 years of age
BS Auerbach, ME Wilson, AM Lake, A Deforest… - Vaccine, 1992 - Elsevier
In a randomized double-blind trial 55 children of 15–24 months and 56 children of 4–6 years
of age previously immunized with whole-cell DTP (WC-DTP) received acellular pertussis …
of age previously immunized with whole-cell DTP (WC-DTP) received acellular pertussis …
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …
R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …
of booster doses in older children and adults. This can be conveniently accomplished by …
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children
ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane …
G Kanra, M Ceyhan, D Vandevoorde… - European journal of …, 1993 - Springer
In two double-blind, randomized, comparative studies involving a total of 218 children, an
acellular pertussis (DTPa) vaccine containing diphtheria and tetanus toxoids and pertussis …
acellular pertussis (DTPa) vaccine containing diphtheria and tetanus toxoids and pertussis …
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell …
K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - …, 1998 - publications.aap.org
Background. The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …
Primary course immunogenicity and reactogenicity of a new diphtheria‐tetanus‐whole cell pertussis vaccine (DTPw)
T Nolan, G Hogg, MA DARCY… - Journal of paediatrics …, 1997 - Wiley Online Library
Objective: To establish safety, immunogenicity, and batch stability of a reformulated whole
cell pertussis based diphtheria‐tetanus‐whole cell pertussis (DTP) vaccine (nDTPw) …
cell pertussis based diphtheria‐tetanus‐whole cell pertussis (DTP) vaccine (nDTPw) …